Selected research
Industry Growth & Trends
Global Pain Management Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Pain Management market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pain Management is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pain Management is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pain Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Pain Management market include Yunnan Baiyao, Teva, Sanofi, J&J, Merck, Eli Lilly, Pfizer, GSK and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pain Management market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pain Management market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pain Management market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pain Management.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Pain Management market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pain Management Market by Company
Yunnan Baiyao
Teva
Sanofi
J&J
Merck
Eli Lilly
Pfizer
GSK
Bayer
AstraZeneca
Purdue
Grunenthal
Endo
Depomed
Allergan
Pain Management Segment by Type
Branded Opioids
NSAIDs
Generic Opioids
Others
Pain Management Segment by Application
Hospitals
Clinics
Others
Pain Management Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pain Management and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain Management.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Pain Management companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Branded Opioids
- NSAIDs
- Generic Opioids
- Others
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Yunnan Baiyao
- Teva
- Sanofi
- J&J
- Merck
- Eli Lilly
- Pfizer
- GSK
- Bayer
- AstraZeneca
- Purdue
- Grunenthal
- Endo
- Depomed
- Allergan
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Pain Management Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Pain Management Market Size by Region (2021-2032)
- 1.4.1 Global Pain Management Market Size by Region (2021-2026)
- 1.4.2 Global Pain Management Market Size by Region (2027-2032)
- 1.5 Key Regions Pain Management Market Size (2021-2032)
- 1.5.1 North America Pain Management Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Pain Management Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Pain Management Market Size Growth Rate (2021-2032)
- 1.5.4 South America Pain Management Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Pain Management Market Size Growth Rate (2021-2032)
2 Pain Management Market by Type
- 2.1 Type Introduction
- 2.1.1 Branded Opioids
- 2.1.2 NSAIDs
- 2.1.3 Generic Opioids
- 2.1.4 Others
- 2.2 Global Pain Management Market Size by Type
- 2.2.1 Global Pain Management Market Size Overview by Type (2021-2032)
- 2.2.2 Global Pain Management Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Pain Management Market Size Forecasted by Type (2027-2032)
- 2.3 Global Pain Management Market Size by Regions
- 2.3.1 North America Pain Management Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Pain Management Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Pain Management Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Pain Management Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Pain Management Market Size Breakdown by Type (2021-2026)
3 Pain Management Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospitals
- 3.1.2 Clinics
- 3.1.3 Others
- 3.2 Global Pain Management Market Size by Application
- 3.2.1 Global Pain Management Market Size Overview by Application (2021-2032)
- 3.2.2 Global Pain Management Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Pain Management Market Size Forecasted by Application (2027-2032)
- 3.3 Global Pain Management Market Size by Regions
- 3.3.1 North America Pain Management Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Pain Management Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Pain Management Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Pain Management Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Pain Management Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Pain Management Industry Trends
- 4.2 Pain Management Industry Drivers
- 4.3 Pain Management Industry Opportunities and Challenges
- 4.4 Pain Management Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Pain Management Revenue (2021-2026)
- 5.2 Global Pain Management Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Pain Management Key Company Headquarters & Area Served
- 5.4 Global Pain Management Company, Product Type & Application
- 5.5 Global Pain Management Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Pain Management Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Pain Management Players Market Share by Revenue in 2025
- 5.6.3 2025 Pain Management Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Yunnan Baiyao
- 6.1.1 Yunnan Baiyao Company Information
- 6.1.2 Yunnan Baiyao Business Overview
- 6.1.3 Yunnan Baiyao Pain Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Yunnan Baiyao Pain Management Product Portfolio
- 6.1.5 Yunnan Baiyao Recent Developments
- 6.2 Teva
- 6.2.1 Teva Company Information
- 6.2.2 Teva Business Overview
- 6.2.3 Teva Pain Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Teva Pain Management Product Portfolio
- 6.2.5 Teva Recent Developments
- 6.3 Sanofi
- 6.3.1 Sanofi Company Information
- 6.3.2 Sanofi Business Overview
- 6.3.3 Sanofi Pain Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Sanofi Pain Management Product Portfolio
- 6.3.5 Sanofi Recent Developments
- 6.4 J&J
- 6.4.1 J&J Company Information
- 6.4.2 J&J Business Overview
- 6.4.3 J&J Pain Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 J&J Pain Management Product Portfolio
- 6.4.5 J&J Recent Developments
- 6.5 Merck
- 6.5.1 Merck Company Information
- 6.5.2 Merck Business Overview
- 6.5.3 Merck Pain Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Merck Pain Management Product Portfolio
- 6.5.5 Merck Recent Developments
- 6.6 Eli Lilly
- 6.6.1 Eli Lilly Company Information
- 6.6.2 Eli Lilly Business Overview
- 6.6.3 Eli Lilly Pain Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Eli Lilly Pain Management Product Portfolio
- 6.6.5 Eli Lilly Recent Developments
- 6.7 Pfizer
- 6.7.1 Pfizer Company Information
- 6.7.2 Pfizer Business Overview
- 6.7.3 Pfizer Pain Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Pfizer Pain Management Product Portfolio
- 6.7.5 Pfizer Recent Developments
- 6.8 GSK
- 6.8.1 GSK Company Information
- 6.8.2 GSK Business Overview
- 6.8.3 GSK Pain Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 GSK Pain Management Product Portfolio
- 6.8.5 GSK Recent Developments
- 6.9 Bayer
- 6.9.1 Bayer Company Information
- 6.9.2 Bayer Business Overview
- 6.9.3 Bayer Pain Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Bayer Pain Management Product Portfolio
- 6.9.5 Bayer Recent Developments
- 6.10 AstraZeneca
- 6.10.1 AstraZeneca Company Information
- 6.10.2 AstraZeneca Business Overview
- 6.10.3 AstraZeneca Pain Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 AstraZeneca Pain Management Product Portfolio
- 6.10.5 AstraZeneca Recent Developments
- 6.11 Purdue
- 6.11.1 Purdue Company Information
- 6.11.2 Purdue Business Overview
- 6.11.3 Purdue Pain Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Purdue Pain Management Product Portfolio
- 6.11.5 Purdue Recent Developments
- 6.12 Grunenthal
- 6.12.1 Grunenthal Company Information
- 6.12.2 Grunenthal Business Overview
- 6.12.3 Grunenthal Pain Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Grunenthal Pain Management Product Portfolio
- 6.12.5 Grunenthal Recent Developments
- 6.13 Endo
- 6.13.1 Endo Company Information
- 6.13.2 Endo Business Overview
- 6.13.3 Endo Pain Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Endo Pain Management Product Portfolio
- 6.13.5 Endo Recent Developments
- 6.14 Depomed
- 6.14.1 Depomed Company Information
- 6.14.2 Depomed Business Overview
- 6.14.3 Depomed Pain Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Depomed Pain Management Product Portfolio
- 6.14.5 Depomed Recent Developments
- 6.15 Allergan
- 6.15.1 Allergan Company Information
- 6.15.2 Allergan Business Overview
- 6.15.3 Allergan Pain Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Allergan Pain Management Product Portfolio
- 6.15.5 Allergan Recent Developments
7 North America
- 7.1 North America Pain Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Pain Management Market Size by Country (2021-2026)
- 7.3 North America Pain Management Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Pain Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Pain Management Market Size by Country (2021-2026)
- 8.3 Europe Pain Management Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Pain Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Pain Management Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Pain Management Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Pain Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Pain Management Market Size by Country (2021-2026)
- 10.3 South America Pain Management Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Pain Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Pain Management Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Pain Management Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst